中国P站

Antimicrobial resistance; Plant-derived compounds; Phytochemicals; Essential oils; Natural products; Anti-virulence agents; Nanoparticles; Traditional medicine; Drug discovery; Therapeutic development; Herbal medicine; Bioactive compounds

Introduction

The urgent global challenge of antimicrobial resistance necessitates novel therapeutic strategies, positioning natural products as a vital source for drug development. Comprehensive reviews delve into diverse plant-derived compounds, meticulously detailing their intricate antimicrobial mechanisms and evaluating their substantial potential as viable alternatives to conventional antibiotics. This research consistently highlights the critical need for new agents to effectively combat the escalating threat of resistance [1].

Phytochemicals demonstrate significant promise as potent antimicrobial agents, particularly against drug-resistant bacteria. Research extensively explores various plant secondary metabolites, elucidating their specific targets and mechanisms of action. This work acknowledges the inherent challenges in their development into effective therapeutic drugs, while strongly emphasizing their crucial role in combating the pervasive issue of antibiotic resistance [2].

Examining the synergistic antimicrobial potential of plant extracts and essential oils, particularly against multidrug-resistant bacteria, reveals an effective approach. Combining these natural compounds has been shown to enhance efficacy, skillfully overcome resistance mechanisms, and reduce toxicity, thereby offering new, innovative strategies for the treatment of infectious diseases [3].

Medicinal plants stand out as a rich source of potent antimicrobial agents, providing a fresh and vital perspective on tackling microbial resistance. Studies discuss a wide array of plant secondary metabolites and their diverse mechanisms against bacteria, fungi, and viruses. This work emphasizes their significant therapeutic potential and the imperative need for rigorous scientific validation to unlock their full benefits [4].

Investigations into phytochemicals as anti-virulence agents reveal a distinct strategy, focusing on disarming bacterial pathogens rather than direct killing. These natural compounds effectively inhibit crucial bacterial processes like quorum sensing, biofilm formation, and toxin production. This approach offers a novel strategy to reduce pathogenicity and cleverly circumvent antimicrobial resistance, presenting a promising alternative [5].

Traditional medicinal plants are recognized for their remarkable dual antimicrobial and anti-inflammatory properties. Research thoroughly explores the bioactive compounds responsible for these combined effects, suggesting their substantial potential in treating infectious diseases while simultaneously managing associated inflammatory responses, thereby providing a holistic therapeutic approach that addresses multiple facets of illness [6].

A comprehensive survey of the current landscape of herbal medicine for antimicrobial applications also outlines crucial future prospects. Discussions cover the demonstrated efficacy of various plant extracts, address the inherent challenges in standardization and clinical translation, and identify emerging technologies. These advancements could harness the therapeutic potential of herbal remedies more effectively in combating persistent microbial infections [7].

Recent advancements in natural product-based drug discovery for new antimicrobial agents are highly significant. Reviews encompass diverse sources, including plants, microbes, and marine organisms, highlighting novel compounds and their mechanisms against resistant pathogens. Innovative screening methods are accelerating the discovery of effective therapeutics, showcasing a dynamic field of research [8].

The green synthesis of nanoparticles using medicinal plants represents a sustainable and innovative method for producing novel antimicrobial agents. This approach details how plant extracts facilitate the formation of nanoparticles and subsequently enhance their antimicrobial efficacy. It offers an eco-friendly and potentially more potent alternative to traditional synthesis methods, marking a significant step forward in material science and medicine [9].

Essential oils hold significant potential as antimicrobial agents, with researchers meticulously elucidating their diverse mechanisms of action against various pathogens. The synergistic effects observed when essential oils are combined with conventional antibiotics are also a key focus. Furthermore, explorations into innovative drug delivery systems aim to enhance their bioavailability and target specificity, ultimately improving therapeutic outcomes and patient care [10].

Description

The escalating threat of antimicrobial resistance has driven an urgent search for novel therapeutic agents, with natural products consistently emerging as a promising avenue. Diverse plant-derived compounds are explored for their antimicrobial mechanisms and potential as alternatives to conventional antibiotics [1]. Phytochemicals, in particular, are discussed as promising antimicrobial agents against drug-resistant bacteria. Researchers investigate various plant secondary metabolites, their specific targets, mechanisms of action, and the challenges in developing them into effective therapeutic drugs, emphasizing their crucial role in combating antibiotic resistance [2]. Medicinal plants are recognized as a rich source of potent antimicrobial agents, offering a fresh perspective on tackling microbial resistance. The discussions encompass various plant secondary metabolites and their mechanisms against bacteria, fungi, and viruses, underscoring their therapeutic potential and the need for rigorous scientific validation [4].

Beyond direct bactericidal effects, a significant area of research investigates phytochemicals as anti-virulence agents. This approach focuses on disarming bacterial pathogens by inhibiting crucial functions like quorum sensing, biofilm formation, and toxin production, rather than directly killing them. This strategy aims to reduce pathogenicity and effectively circumvent antimicrobial resistance [5]. Essential oils also hold considerable potential as antimicrobial agents. Studies meticulously elucidate their diverse mechanisms of action against various pathogens, covering a broad spectrum of inhibitory activities [10].

Synergistic approaches are gaining traction, with reviews examining the combined antimicrobial potential of plant extracts and essential oils, especially against multidrug-resistant bacteria. The combination of these natural compounds enhances efficacy, helps overcome resistance mechanisms, and can reduce toxicity, offering new, innovative strategies for infectious disease treatment [3]. Furthermore, traditional medicinal plants are explored for their dual antimicrobial and anti-inflammatory properties. Research delves into the bioactive compounds responsible for these combined effects, suggesting their potential in treating infectious diseases while simultaneously managing associated inflammatory responses, thereby providing a holistic therapeutic approach [6].

The current landscape of herbal medicine for antimicrobial applications is being surveyed, with an outline of future prospects. Discussions cover the efficacy of various plant extracts, address challenges in standardization and clinical translation, and identify emerging technologies that could harness their therapeutic potential more effectively in combating microbial infections [7]. Recent advancements in natural product-based drug discovery for new antimicrobial agents highlight diverse sources like plants, microbes, and marine organisms. They discuss novel compounds, their mechanisms against resistant pathogens, and innovative screening methods that accelerate the discovery of effective therapeutics [8]. A particularly promising area involves the green synthesis of nanoparticles using medicinal plants as a sustainable method to produce novel antimicrobial agents. This approach details how plant extracts facilitate nanoparticle formation and enhance their antimicrobial efficacy, offering an eco-friendly and potentially more potent alternative to traditional synthesis methods [9].

Conclusion

Research extensively explores natural products, primarily from plants, as crucial sources for developing new antimicrobial agents to combat rising drug resistance. Diverse plant-derived compounds, including various phytochemicals and essential oils, are detailed for their potent antimicrobial mechanisms and their potential as alternatives to conventional antibiotics. Studies highlight the urgent need for novel agents to address multidrug-resistant bacteria and other pathogens. Investigations delve into specific targets and mechanisms of action, such as inhibiting quorum sensing, biofilm formation, and toxin production, offering anti-virulence strategies that disarm pathogens rather than directly killing them. Synergistic approaches, combining plant extracts and essential oils, demonstrate enhanced efficacy, ability to overcome resistance, and reduced toxicity. The field also covers traditional medicinal plants with dual antimicrobial and anti-inflammatory properties, providing holistic therapeutic approaches. Recent advancements include the green synthesis of nanoparticles using medicinal plants for eco-friendly and potent antimicrobial solutions. The current status and future prospects of herbal medicine, alongside innovative drug discovery methods for diverse natural sources, emphasize the ongoing effort to harness nature's therapeutic potential effectively against microbial infections.

References

1. Ahmed Y, Khaled A, Hassan A (2024) .Molecules 29:1335.

   , ,

2. Md. AI, Md. RI, Md. SU (2023) .Molecules 28:5464.

   , ,

3. Samira B, Mojtaba A, Mohammad RR (2022) .Antibiotics (Basel) 11:154.

   , ,

4. Neveen KG, Al-Waled ME, Eman GME (2021) .Plants (Basel) 10:2368.

   , ,

5. Saheem A, Mohammed A, S. A (2020) .Molecules 25:4976.

   , ,

6. Anam F, Aisha IK, Asma S (2022) .Plants (Basel) 11:1876.

   , ,

7. Sara FE, Mohamed AE, Marwa MA (2023) .Molecules 28:853.

   , ,

8. Hafiz MNI, Muhammad B, Muhammad AK (2020) .Molecules 25:2529.

   , ,

9. Nagendra SK, K. SL, J. LR (2022) .Curr Pharm Des 28:2521-2534.

   , ,

10. Anamika K, Anil K, Surbhi S (2023) .Molecules 28:7306.

    , ,